It is not a change in the stool colour, but a sign that blood is coming from the top section of the digestive system, such as, small intestine or stomach
Two classes of medications designed as novel therapeutic strategies for DM2, namely Glucagon-Like Peptide-1 receptor agonists (GLP-1Ra) and Sodium-glucose cotransporter-2 inhibitors (SGLT2i), have demonstrated to reduce CV mortality and the occurrence of heart failure (HF) in patients with DM2 [8,9,10]
Across all this human data, the rodent thyroid tumor signal has not emerged in people
Bruckschlegel, G
Since Tirzepatide offers a dual-action approach, program structures may differ slightly, reflecting its advanced mechanism of action and the individualized care required
Future research into once-weekly insulins could reduce this number even further